Author

Amy Hart

SERUM PROTEIN PROFILES DIFFER WITH USTEKINUMAB AND ADALIMUMAB TREATMENT IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE
SERUM PROTEIN PROFILES DIFFER WITH USTEKINUMAB AND ADALIMUMAB TREATMENT IN MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE

Amy Hart  et al.

IMPACT OF THE HLA-DQA1*05 ALLELE ON LOSS OF RESPONSE AND PRESENCE OF ANTI-DRUG ANTIBODIES TO USTEKINUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS
IMPACT OF THE HLA-DQA1*05 ALLELE ON LOSS OF RESPONSE AND PRESENCE OF ANTI-DRUG ANTIBODIES TO USTEKINUMAB IN CROHN’S DISEASE AND ULCERATIVE COLITIS PATIENTS

Amy Hart  et al.

Item 1 - 2 / 2
1